CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
- Update frequency
- every 3 days
- Average duration
- 25 minutes
- Episodes
- 461
- Years Active
- 2020 - 2025
Ensuring Linkage to Care for Patients Diagnosed With Hepatitis Delta Virus
In this episode, Nancy Reau, MD, and Lydia Tang, MBChB, discuss how to increase linkage to care rates for persons with hepatitis D virus, including:
- Updates on currently low rates of linkage to care
- Ba…
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerability in pregnant people, those trying to conceive, …
How to Screen for Hepatitis Delta Virus
In this episode, Coleman I. Smith, MD, and Lydia Tang, MBChB, discuss how to screen for hepatitis delta virus (HDV), including:
- Algorithm for evaluation of HDV
- Diagnosis of different stages of HDV infe…
Australian Perspectives on Advances in HIV
In this episode, 2 Australian HIV experts share their thoughts on some of the most important HIV insights gained during the past year in the context of HIV care in Australia.
Specifically, the facult…
Canadian Perspectives on Advances in HIV Treatment and Prevention
In this episode, Canadian HIV experts share their thoughts on some of the most important new insights from HIV treatment and prevention research over the past year.
Specifically, the faculty discuss t…
Perspectives From Latin America on Advances in HIV PrEP
In this episode, 2 HIV experts from Latin America share their thoughts on the current status of HIV prevention strategies in the region, including recent successes and ongoing challenges. Specificall…
European Perspectives on Advances in HIV Treatment
In this episode, 2 European HIV experts share their thoughts on some of the most important new antiretroviral therapy insights from HIV research over the past year.
Specifically, the faculty discuss f…
Diagnosis and Management of Patients With Long COVID
In this episode, Alba Azola, MD, and Monica Verduzco-Gutierrez, MD, discuss diagnosis and management of long COVID, including:
- Definitions of post COVID conditions
- Diagnosis, including symptoms and cl…
The Role of College Campuses in HIV PrEP Uptake
In this episode, Kenric Ware, PharmD, AAHIVP, discusses the role of college campuses in HIV pre-exposure prophylaxis (PrEP) uptake for adolescents, including the following.
- PrEP awareness and educatio…
How Clinic Facilities Can Prepare for Long-Acting Injectable Antiretroviral Therapy
In this episode, Eric Florence, MD, PhD, discusses how clinics can prepare for the implementation of long-acting injectable antiretroviral therapy, including:
- Clinical infrastructure
- Ensuring adequate …
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those wi…
Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe
In this episode, Jens D. Lundgren, MD, DMSc, and Barbara Rath, MD, PhD, HDR, discuss emerging insights on outpatient management of acute COVID-19 and long COVID in Europe, including:
- Current COVID-19 …
Administration of LA ART by Community Nurses in France
In this episode, Laurence Slama, MD, PhD, describes some of the ways that her clinic is attempting to make IM injections of long-acting antiretroviral therapy more sustainable long term. She explains…
PrEP Considerations for Transgender and Nonbinary Individuals
In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:
- Providing gender-affirming care
- Integrating…
Optimizing PrEP Selection and Persistence for MSM
In this episode, Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, discusses optimizing HIV pre-exposure prophylaxis (PrEP) selection and persistence for men who have sex with men (MSM), includi…
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 treatments and the possibility for antiviral resistance, including:
- Treatment res…
What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?
Fernando Carnavali, MD; Rasika Karnik, MS, MD; and Renslow Sherer, MD, discuss long COVID, including:
- Long COVID prevention strategies, including COVID-19 vaccination
- Long COVID treatment approaches
- Str…
Should We Be Concerned About Viral Rebound With Antiviral Agents?
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 rebound, including:
- Prevalence of COVID-19 rebound
- COVID-19 rebound and antiviral …
ART Selection in Treatment-Naive PWH: Weight Gain Considerations
In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes a review of the following studies on ART…
Selecting First-line ART in Treatment-Naive Persons With HIV
In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes:
- DHHS Treatment Guideline recommendations
- …